Streetbeat News

Products Services

RSLS

ReShape Lifesciences, Inc. (NASDAQ:RSLS) experienced a nearly 70% surge in its stock price after-hours following the announcement of FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. The approval is seen as a significant growth catalyst for the company's Lap-Band franchise. The new Lap-Band 2.0 features FLEX Technology, designed to improve the patient experience by allowing larger pieces of food to pass through more easily.

Portfolio Pulse from Ryan Gustafson

December 12, 2023 | 10:19 pm

CALM

Cal-Maine Foods, Inc. (NASDAQ:CALM) stock dropped in after-hours trading following the announcement that one of its Kansas facilities tested positive for highly pathogenic avian influenza, affecting about 684,000 laying hens, or 1.6% of its total flock. The company has halted production at the facility and is seeking to offset the impact by securing production from other locations. No other facilities have tested positive, and the company emphasized its strong biosecurity measures.

Portfolio Pulse from Ryan Gustafson

December 12, 2023 | 10:10 pm

CVSI

CV Sciences, Inc. (OTCQB:CVSI) has completed the acquisition of Cultured Foods, a European manufacturer and distributor of vegan foods, for up to $535,000. The deal includes a cash payment, shares of CVSI stock, and a potential earn-out. This acquisition allows CV Sciences to expand its +PlusCBD products in Europe and introduce Cultured Foods' products in the US. The acquisition is expected to be accretive in its first year and contribute to scaling economics. CVSI shares dropped 6.2657% to $0.0374 per share after the announcement.

Portfolio Pulse from Jelena Martinovic

December 12, 2023 | 9:52 pm

TTWO

Take-Two Interactive Software Inc's (NASDAQ:TTWO) upcoming 'Grand Theft Auto 6' is set to release in 2025 exclusively for PlayStation 5 and Xbox Series X and S, with no immediate PC launch. This decision has caused a split in the PC gaming community. Ex-Rockstar animator Mike York explained that the delay in the PC version is due to prioritizing platforms that sell more and the complexity of developing for various PC configurations. He urged patience and highlighted that avoiding early PC release also protects the game from hackers and modders.

Portfolio Pulse from Franca Quarneti

December 12, 2023 | 9:41 pm

CALM

Cal-Maine Foods' stock is trading lower following the report of a highly pathogenic avian influenza outbreak at one of its Kansas facilities, affecting around 684,000 laying hens.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:38 pm

EOSE

Eos Energy Enterprises, Inc. (NASDAQ:EOSE) and Pine Gate Renewables have expanded their partnership with a new MOU for an additional 500MWh of energy storage. This agreement builds on their collaboration since 2021 and is expected to evolve into a final MSA by March 29, 2024. The deal adds 500MWh to Eos's project pipeline and is currently categorized as a letter of intent.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:32 pm

CALM

Cal-Maine Foods has reported a case of Avian Influenza at its Kansas facility, impacting approximately 1.6% of its total flock. Production at the affected facility has been halted, following USDA protocols. The company is seeking alternative production means to reduce customer disruption.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:29 pm

RSLS

ReShape Lifesciences Inc. has received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:28 pm

TNDM

Tandem Diabetes Care, Inc. has launched Tandem Source, a new diabetes management platform that consolidates features from previous offerings into one central platform. It provides comprehensive data reporting for insulin pump users and healthcare providers, with easy-to-use reports, automatic data transfers, and a web-based pump uploader. The platform is now available in the U.S., with international availability expected in 2024. Early feedback has been positive, and the company plans to expand access to other countries next year.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:16 pm

BIOL

Biolase has completed a trial program for its Waterlase iPlus All Tissue Laser, receiving unanimously positive feedback from dentists. The trial results showed 100% performance satisfaction and a recommendation for broader adoption in dental practices.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 9:12 pm